Skip to main content

Day: June 28, 2022

Larimar Therapeutics Announces Oral Presentation at the Upcoming Gordon Research Conference on Mitochondria and Chloroplasts

BALA CYNWYD, Pa., June 28, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that biomarker studies that have identified genes that are differentially expressed between healthy individuals and those with Friedreich’s ataxia will be featured in an oral presentation at the upcoming Gordon Research Conference on Mitochondria and Chloroplasts during the session on “Organelle Biology Translated into Medicine and Agriculture.” The conference will take place July 17 – 22, 2022 at Mount Snow in West Dover, Vermont. Details on the presentation are shown below.Presentation Title: Identification of Differentially Expressed Genes in Friedreich’s Ataxia Patients   Presenting Author: David Bettoun,...

Continue reading

Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development

Advances lead optimization, first-in-human dose prediction and formulation development PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) — Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for scientists working in small molecule drug discovery and translational research. Derived from the industry-leading Simcyp Simulator, Simcyp Discovery increases confidence in early-stage development decisions using physiologically-based pharmacokinetic (PBPK) modeling and simulation. “We are pleased to offer our new Simcyp Discovery Simulator to help identify and move forward the most promising new drug candidates for further investigation,” said William F. Feehery, Ph.D., CEO of Certara. “The failure rate from preclinical to clinical studies is high with...

Continue reading

Outstanding Results from Wyoming Rare Earths Drilling

Higher grade assays amplify potential as one of the largest deposits in North America PHOENIX, June 28, 2022 (GLOBE NEWSWIRE) — American Rare Earths Limited (ASX: ARR, OTCQB: ARRNF, FSE: 1BHA) (ARR or ‘the Company’) is pleased to announce highly promising assay results from recent exploration drilling in the Halleck Creek Rare Earth project in Wyoming, USA. These preliminary results are from four of nine holes drilled at Halleck Creek. Results for the remaining five holes are pending assay analysis and expected soon. During the period from March to April 2022 the Company drilled nine holes for 917 meters and collected 650 core samples. The assay results from 280 samples from four core holes demonstrate consistent rare earth mineralization associated with clinopyroxene quartz monzonite (CQM) rocks of the Red Mountain...

Continue reading

Infinera and NEC to Modernize Neutral Networks’ Mexico to United States Fiber Optic Network with Industry-leading ICE6 800G Solution

SAN JOSE, Calif. and MEXICO CITY and TOKYO, June 28, 2022 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) and NEC Corporation (NEC: TSE: 6701) announced today that Neutral Networks deployed Infinera’s ICE6 technology for its new transnational neutral fiber optic network NEXT. The companies worked closely together to design the largest optical network modernization between Mexico and the United States, making it the largest project of its kind in the region within the last 20 years. With Infinera’s ICE6 800G coherent technology, Neutral Networks’ NEXT network will provide high-capacity services and pave the way for future growth in the region. Neutral Networks provides connectivity to carriers, data centers, and enterprise customers on its existing 175-mile network. With NEXT, Neutral Networks will establish a neutral, diverse, 100%...

Continue reading

ProSomnus® to Open New Global Headquarters and Manufacturing Center of Excellence, Increasing Manufacturing Capacity and Efficiency

32,219-square-foot facility will quintuple growth and create local jobs All ProSomnus medical devices are made in Pleasanton, CA, USA SAN FRANCISCO, June 28, 2022 (GLOBE NEWSWIRE) — ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced plans for a new 32,219-square-foot facility in Pleasanton, California, USA. The facility will serve as the company’s global headquarters and manufacturing center of excellence. The move will quintuple manufacturing capacity, enabling ProSomnus to meet the rapidly growing demand for the company’s FDA-cleared oral appliance therapy devices. ProSomnus expects to begin operations at the facility in January 2023. In addition to expanding capacity, the purpose-built facility will allow ProSomnus, a pioneer in precision oral appliance...

Continue reading

II-VI Incorporated Obtains All Governmental Regulatory Approvals to Complete Acquisition of Coherent, Inc. and Sets Expected Closing Date

PITTSBURGH and SANTA CLARA, Calif., June 28, 2022 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq: IIVI) (“II-VI”) and Coherent, Inc. (Nasdaq: COHR) (“Coherent”) today announced that II-VI has obtained antitrust clearance from the State Administration for Market Regulation of the People’s Republic of China (“SAMR”) for II-VI’s pending acquisition of Coherent. The clearance decision from SAMR satisfies the closing condition set forth in the previously announced merger agreement regarding the receipt of antitrust approvals. II-VI expects the closing of its acquisition of Coherent (the “Merger”) to occur on or about July 1, 2022. Under the terms of merger agreement, each share of Coherent common stock will be converted into the right to receive $220.00 in cash and 0.91 of a share of II-VI common stock upon the completion of the transaction. Allen...

Continue reading

Form 8.3 – [Secure Income REIT plc – 27 06 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SECURE INCOME REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [LXi REIT plc – 27 06 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXI REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

With 28.2% CAGR, Global Big Data as a Service Market Size Worth USD 93.52 Billion in 2028

According to Fortune Business Insights, the global Big Data as a Service Market Size is projected to reach USD 93.52 billion in 2028, at CAGR of 28.2% during forecast period [2021-2028]; Growing E Commerce Industry to Aid in Expansion Pune, India, June 28, 2022 (GLOBE NEWSWIRE) — The global big data as a service market size is expected to showcase significant growth by reaching USD 93.52 Billion by 2028. This is attributable to the rapid adoption of big data as a service by social media platforms, coupled with the growing e-commerce industry worldwide. According to a recent report by Fortune Business Insights, titled, “Big Data as a Service (BDaaS) Market Size, Share & COVID-19 Impact Analysis, By Solution (Hadoop-as-a-Service, Data-as-a-Service and Data Analytics-as-a-Service), By Deployment Model (Public Cloud, Private Cloud...

Continue reading

Form 8.3 – [Ideagen plc – 28 06 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.